{"nct_id":"NCT02447003","title":"Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2015-06-11","start_date_type":"ACTUAL","primary_completion_date":"2019-02-18","primary_completion_date_type":"ACTUAL","completion_date":"2020-01-31","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}